2002
Factors Associated with HIV Seroprevalence among Participants Enrolling at a Needle Exchange Program
Vertefeuille J, Strathdee S, Huettner S, Brown M, Vlahov D. Factors Associated with HIV Seroprevalence among Participants Enrolling at a Needle Exchange Program. Journal Of Drug Issues 2002, 32: 1125-1138. DOI: 10.1177/002204260203200408.Peer-Reviewed Original ResearchInjection drug usersHIV seroprevalenceHIV-seronegative counterpartsHIV-seropositive individualsHIV risk factorsDaily cocaine injectionsDaily heroin injectionDrug use characteristicsHarms of drugsHIV seropositive statusNeedle exchange programsLogistic regression modelsSpeedball injectionHIV antibodiesHIV infectionHeroin injectionProspective studyRisk factorsCocaine injectionFactors AssociatedDrug usersMultivariate modelProgram entryHIVSeroprevalence
2001
Multiple Access to Sterile Syringes for Injection Drug Users: Vending Machines, Needle Exchange Programs and Legal Pharmacy Sales in Marseille, France
Moatti J, Vlahov D, Feroni I, Perrin V, Obadia Y. Multiple Access to Sterile Syringes for Injection Drug Users: Vending Machines, Needle Exchange Programs and Legal Pharmacy Sales in Marseille, France. European Addiction Research 2001, 7: 40-45. PMID: 11316925, DOI: 10.1159/000050713.Peer-Reviewed Original ResearchConceptsInjection drug usersNeedle exchange programsSterile syringesNEP usersNew syringesPharmacy salesCharacteristics of IDUsDrug usersPrevention of HIVDrug use characteristicsHIV prevention programsSelf-administered questionnaireMethadone programsHeroin injectorsUseful adjunctPrevention programsInfectious diseasesProgram utilizationHIVSyringesPharmacyExchange programsQuestionnaireBuprenorphineDisease
1999
Direct Comparison of Time to AIDS and Infectious Disease Death Between HIV Seroconverter Injection Drug Users in Italy and the United States: Results From the ALIVE and ISS Studies
Pezzotti P, Galai N, Vlahov D, Rezza G, Lyles C, Astemborski J. Direct Comparison of Time to AIDS and Infectious Disease Death Between HIV Seroconverter Injection Drug Users in Italy and the United States: Results From the ALIVE and ISS Studies. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 20: 275-282. PMID: 10077177, DOI: 10.1097/00042560-199903010-00010.Peer-Reviewed Original ResearchConceptsInjection drug usersDate of seroconversionYear of seroconversionMedian timeRelative hazardGroups of IDUsDrug usersInfectious diseasesCohort of IDUsFirst positive HIV testClinic-based cohortSimilar median timeHIV disease progressionProspective cohort studyPositive HIV testInjection drug useCommunity-based cohortHIV-positive individualsInfectious disease deathsTime of seroconversionDrug use characteristicsTerms of ageProportion of womenALIVE studyCohort study
1992
Correlates of human immunodeficiency virus infection in intravenous drug users: are treatment‐program samples misleading?
ALCABES P, VLAHOV D, ANTHONY J. Correlates of human immunodeficiency virus infection in intravenous drug users: are treatment‐program samples misleading? Addiction 1992, 87: 47-54. PMID: 1311973, DOI: 10.1111/j.1360-0443.1992.tb01899.x.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHIV-1 seropositivityDrug usersTreatment programHuman immunodeficiency virus (HIV) infectionHIV-1 seroprevalenceImmunodeficiency virus infectionHuman immunodeficiency virusDrug use characteristicsCommunity-based sampleDrug use behaviorsImmunodeficiency virusPossible selection biasRisk factorsVirus infectionType 1SeropositivityTreatmentCommunity service agenciesConfidential interviewsSelection biasSubjectsUse behaviorsExtensive distributionCorrelates